ATE537454T1 - Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15 - Google Patents
Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15Info
- Publication number
- ATE537454T1 ATE537454T1 AT07108852T AT07108852T ATE537454T1 AT E537454 T1 ATE537454 T1 AT E537454T1 AT 07108852 T AT07108852 T AT 07108852T AT 07108852 T AT07108852 T AT 07108852T AT E537454 T1 ATE537454 T1 AT E537454T1
- Authority
- AT
- Austria
- Prior art keywords
- gdf
- heart failure
- atrial fibrillation
- patients
- assessing heart
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 102000000597 Growth Differentiation Factor 15 Human genes 0.000 title abstract 3
- 108010041834 Growth Differentiation Factor 15 Proteins 0.000 title abstract 3
- 206010019280 Heart failures Diseases 0.000 title abstract 3
- 206010003658 Atrial Fibrillation Diseases 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/495—Transforming growth factor [TGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07108852A EP1995596B1 (de) | 2007-05-24 | 2007-05-24 | Verfahren zum Beurteilen von Herzinsuffizienz bei Patienten mit Vorhofflimmern mittels GDF-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE537454T1 true ATE537454T1 (de) | 2011-12-15 |
Family
ID=38190863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07108852T ATE537454T1 (de) | 2007-05-24 | 2007-05-24 | Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7955854B2 (de) |
| EP (1) | EP1995596B1 (de) |
| JP (1) | JP5015318B2 (de) |
| AT (1) | ATE537454T1 (de) |
| ES (1) | ES2379104T3 (de) |
| WO (1) | WO2008142110A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5198565B2 (ja) * | 2007-08-30 | 2013-05-15 | エフ．ホフマン−ラ ロシュ アーゲー | 心疾患に関連する又は関連しないｇｄｆ−１５の上昇の区別のための手段及び方法 |
| WO2009087190A1 (en) * | 2008-01-08 | 2009-07-16 | Roche Diagnostics Gmbh | Means and methods for assessing the risk of patients presenting to emergency units based on gdf-15 |
| JP5592487B2 (ja) | 2009-07-27 | 2014-09-17 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 心不全の評価におけるミメカンの使用 |
| DK2491400T3 (en) * | 2009-10-21 | 2016-01-11 | Mycartis N V | Biomarker FOR DIAGNOSIS, PREDICTION AND / OR FORECAST OF ACUTE HEART FAILURE AND USES THEREOF |
| EP2439535A1 (de) * | 2010-10-07 | 2012-04-11 | F. Hoffmann-La Roche AG | Diagnose von Herzerkrankungen im Zusammenhang mit Diabetes und GDF-15 und Troponin als Prädiktor für die Entwicklung von Diabetes mellitus Typ 2 |
| KR101230088B1 (ko) | 2010-11-24 | 2013-02-05 | 연세대학교 산학협력단 | 심방세동의 예후 예측 방법 |
| JP6820748B2 (ja) * | 2014-06-13 | 2021-01-27 | ノバルティス アーゲー | Ｇｄｆ−１５を減少させるためのセレラキシンの使用 |
| WO2017150314A1 (ja) | 2016-02-29 | 2017-09-08 | 公立大学法人横浜市立大学 | 去勢抵抗性前立腺癌を検出する方法及び検出試薬 |
| BR112018073214A2 (pt) * | 2016-06-17 | 2019-04-16 | F. Hoffmann-La Roche Ag | métodos para a previsão do risco de recorrência da fibrilação atrial, para o diagnóstico de fibrilação atrial em um indivíduo, para o monitoramento de uma terapia e para a classificação da fibrilação e utilizações do biomarcador |
| WO2018167447A1 (en) | 2017-03-14 | 2018-09-20 | University Of Sheffield | Low dose aspirin (1-50 mg) together with antiplatelets such as ticagrelor of anticoagulants |
| JP7127422B2 (ja) | 2017-08-30 | 2022-08-30 | 東ソー株式会社 | 癌を検出する方法及び検出試薬 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005124364A1 (en) * | 2004-06-15 | 2005-12-29 | F. Hoffmann-La Roche Ag | The use of cardiac hormones for diagnosing the risk of suffering from a cardiovascular complication as a consequence of cardiotoxic medication |
| CN101120256A (zh) * | 2005-02-17 | 2008-02-06 | 霍夫曼-拉罗奇有限公司 | Nt-原anp/nt-原bnp的比值用于诊断心功能障碍的用途 |
| CA2660691C (en) * | 2006-08-04 | 2020-01-14 | Medizinische Hochschule Hannover | Means and methods for assessing the risk of cardiac interventions based on gdf-15 |
| JP5198565B2 (ja) * | 2007-08-30 | 2013-05-15 | エフ．ホフマン−ラ ロシュ アーゲー | 心疾患に関連する又は関連しないｇｄｆ−１５の上昇の区別のための手段及び方法 |
-
2007
- 2007-05-24 EP EP07108852A patent/EP1995596B1/de active Active
- 2007-05-24 ES ES07108852T patent/ES2379104T3/es active Active
- 2007-05-24 AT AT07108852T patent/ATE537454T1/de active
-
2008
- 2008-05-21 JP JP2010508842A patent/JP5015318B2/ja active Active
- 2008-05-21 WO PCT/EP2008/056261 patent/WO2008142110A1/en active Application Filing
-
2009
- 2009-11-19 US US12/621,560 patent/US7955854B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20100159608A1 (en) | 2010-06-24 |
| JP2010528275A (ja) | 2010-08-19 |
| ES2379104T3 (es) | 2012-04-20 |
| EP1995596B1 (de) | 2011-12-14 |
| JP5015318B2 (ja) | 2012-08-29 |
| WO2008142110A1 (en) | 2008-11-27 |
| US7955854B2 (en) | 2011-06-07 |
| EP1995596A1 (de) | 2008-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE537454T1 (de) | Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15 | |
| DE602006014535D1 (de) | Verwendung von nt-proanp und nt-probnp zur diagnose von herzerkrankungen | |
| JP2010517618A5 (de) | ||
| WO2008132464A3 (en) | Mek5 and related proteins as biomarkers of neurodegenerative diseases | |
| JP2012529655A5 (de) | ||
| WO2009092386A3 (en) | A new method to measure and characterize microvesicles in the human body fluids | |
| GB201021399D0 (en) | Oligonucleotide probe set and methods of microbiota profiling | |
| CA2726071A1 (en) | Blood glucose monitoring device | |
| WO2009047283A3 (en) | Means and methods for monitoring myocardial infarction and its treatment | |
| JP2018536170A5 (de) | ||
| BR112015014232A2 (pt) | lesão renal aguda | |
| AR071034A1 (es) | Uso de la catepsina c en el diagnostico de susceptibilidad al dolor y para el tratamiento del dolor | |
| ATE550668T1 (de) | Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis | |
| WO2008061978A3 (en) | Means and methods for optimization of diagnostic and therapeutic approaches in chronic artery disease based on the detection of troponin t and nt-probnp | |
| CY1111602T1 (el) | ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ IN VIVO ΤΗΣ ΝΕΥΡΟΤΡΥΨΙΝΗΣ, ΧΡΗΣΗ ΤΗΣ ΜΕΘΟΔΟΥ ΚΑΙ ΧΡΗΣΗ TOY C-ΤΕΡΜΑΤΙΚΟΥ 22-kDa ΘΡΑΥΣΜΑΤΟΣ ΤΗΣ ΑΓΡΙΝΗΣ ΩΣ ΒΙΟΔΕΙΚΤΗ ΕΙΣ ΤΗΝ ΔΙΑΓΝΩΣΗ ΚΑΙ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΔΙΑΤΑΡΑΧΩΝ ΠΟΥ ΕΧΟΥΝ ΣΧΕΣΗ ΜΕ ΝΕΥΡΟΤΡΥΨΙΝΗ | |
| JP2008212179A (ja) | ストレス強度演算方法、及びストレス強度演算装置 | |
| EA201490576A1 (ru) | Молекулярный маркер для ранней диагностики мезотелиомы плевры у пациентов и способы для анализа его экспрессии | |
| RU2008147047A (ru) | Способ диагностики хронического генерализованного пародонтита с агрессивным течением | |
| RU2008131766A (ru) | Способ реабилитации опорно-двигательного аппарата | |
| ATE503847T1 (de) | Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten | |
| ATE483983T1 (de) | Verfahren zur diagnose von chronischem stress und verwandten erkrankungen | |
| Matheson et al. | A novel, microvascular evaluation method and device for early diagnosis of peripheral artery disease and chronic limb-threatening ischemia in individuals with diabetes | |
| RU2010115050A (ru) | Способ оценки функционального состояния спинного мозга | |
| RU2019133312A (ru) | Способ ранней доклинической диагностики болезни Паркинсона по концентрации катехоламинов в слезной жидкости пациента | |
| Simpson et al. | Abnormal sweating in diabetes--implications for screening for diabetic peripheral neuropathy. |